We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
QCG
251
Quadrant Capital Group
Ohio
– -$16K -72 Closed
GI
252
Gradient Investments
Minnesota
– -$14K -65 Closed
GKIM
253
GW&K Investment Management
Massachusetts
– -$13K -60 Closed
Daiwa Securities Group
254
Daiwa Securities Group
Japan
– -$12K -57 Closed
PO
255
Private Ocean
California
– -$12K -55 Closed
AIC
256
Archer Investment Corporation
Indiana
– -$10.8K -50 Closed
AWM
257
Atticus Wealth Management
Florida
– -$11K -50 Closed
BFG
258
Baron Financial Group
New Jersey
– -$10.8K -50 Closed
COCM
259
Charter Oak Capital Management
New Hampshire
– -$11K -50 Closed
EVM
260
Eaton Vance Management
Massachusetts
– -$11K -50 Closed
FCM
261
Firestone Capital Management
Florida
– -$11K -50 Closed
LWA
262
Lenox Wealth Advisors
New York
– -$10K -44 Closed
JCM
263
Jacobi Capital Management
Pennsylvania
– -$9K -42 Closed
AssetMark Inc
264
AssetMark Inc
California
– -$9K -40 Closed
SIAP
265
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
– -$9K -40 Closed
CFGS
266
Concourse Financial Group Securities
Alabama
– -$8K -39 Closed
WT
267
Washington Trust
Rhode Island
– -$7K -34 Closed
ME
268
McIlrath & Eck
Washington
– -$7K -31 Closed
HWMA
269
Heritage Wealth Management (Arizona)
Arizona
– -$7K -30 Closed
RIA
270
RPG Investment Advisory
California
– -$7K -30 Closed
CFB
271
Cullen/Frost Bankers
Texas
– -$5K -25 Closed
EIP
272
Ellis Investment Partners
Pennsylvania
– -$5K -25 Closed
HWA
273
Heritage Wealth Advisors
Virginia
– -$5.42K -25 Closed
LWA
274
Lowe Wealth Advisors
Maryland
– -$5K -25 Closed
PFA
275
Professional Financial Advisors
Nebraska
– -$5K -25 Closed
8 9 10
11
12

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.